Logo AQ

Aquarray GmbH

Aquarray GmbH is a biotechnology company founded in April 2018 as a spin-off of the Karlsruhe Institute of Technology in Germany. Aquarray’s proprietary Droplet Microarray (DMA) is a product innovation which enables novel highly miniaturized cell based screenings. The DMA is saving costs by miniaturization, while both accelerating screening, and increasing the predictivity of screening results by enabling physiologically more relevant screening models. DMA aims to address the main needs evidenced by fundamental life science research, personalized drug screenings and Pharma drug discovery campaigns. The founders’ team combines research and commercial expertise, bringing together expertise and decades of experience in chemistry, surface science, biophysics, biology, medical industry and entrepreneurship. Since our inception to nowadays, our work and gamechanging solution has been welcomed and recognised. We have raised an important amount of public and private investment, we have secured important partnerships with key actors in the value chain as well. We have started to generate interest and potential market demand for our product from Pharma companies and research institutes.

Video Slide

Aquarray Screening System

Download (3 MB)
DMA Chemical and Biological Screening
Download (2 MB)
use case certus
Download (565 KB)



Aquarray GmbH
Hermann-von-Helmholtz-Platz 6
76344 Eggenstein-Leopoldshafen

Phone +4915770428225
E-mail: wolfgang.sipos@aquarray.com